Commentary: Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy - Top-Institutions - MDSpire

Analysis of Acute and Long-Term Toxicity in Prostate Cancer Patients Undergoing Moderately Versus Ultra-Hypofractionated Radiotherapy

  • By

  • Toufic Eid

  • Tarek Al-Bitar

  • Osama Mohamad

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Los Angeles
    University of California, Los Angeles

    Los Angeles, California

    Key Differentiators

    • Radiation Oncology

  • #2

    Duke University
    Duke University

    Durham, North Carolina

    Key Differentiators

    • Radiation Oncology

  • #3

    Skåne University Hospital
    Skåne University Hospital

    Lund, Sweden

    Key Differentiators

    • Radiation Oncology

  • #4

    Saint-Louis Hospital
    Saint-Louis Hospital

    Paris, France

    Key Differentiators

    • Radiation Oncology

  • #5

    Perelman School of Medicine
    Perelman School of Medicine

    Philadelphia, Pennsylvania

    Key Differentiators

    • Radiation Oncology

Original Source(s)

Commentary: Acute and late toxicity in prostate cancer patients treated with moderately vs ultra-hypofractionated radiotherapy

  • by Toufic Eid, Tarek Al-Bitar, Osama Mohamad

  • July 20, 2026

Related Content

Prognostic analysis of first-recurrence/metastasis esophageal squamous cell carcinoma: chemoimmunotherapy combined with radiotherapy as one of the optimal clinical management strategies

Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study

Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 mice